Uncovering how a molecule responsible for immune “brakes” directs skin defenses
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Dec-2025 03:11 ET (29-Dec-2025 08:11 GMT/UTC)
New research identifies NF-kappa-B-activating protein-like (NKAPL) as a potent tumor suppressor in non-small cell lung cancer (NSCLC).
Oak Brook, IL – Volume 34 of SLAS Discovery includes two original research articles, one short communication and one entry in the upcoming Special Issue on EUOS/SLAS Joint Challenge: Compound Solubility.